Published 1 year ago

Pfizer to invest more than $2.5 bln to expand European manufacturing

Summary by Ground News

Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot. Pfizer to invest more than $2.5 billion at its drug-making plants in Belgium and Ireland. China has started taking steps to ease its zero-COVID policy, fuelling a mix of relief and worry.

0 Articles

All

Left

Center

Right

Reuters

Pfizer to invest more than $2.5 bln to expand European manufacturing

Pfizer Inc is investing more than $2.5 billion at its drug making plants in Belgium and Ireland, gearing up to launch new products it hopes can replace lost revenue as patents expire and COVID-19 vaccine sales decline.

1 year ago·United Kingdom

Read Full Article

The Globe & Mail

Pfizer to invest more than US$2.5-billion to expand European manufacturing

Pfizer says it plans to spend more than €1.2-billion to expand its Puurs, Belgium, manufacturing site, matching the investment at its Dublin, Ireland, plant announced on Thursday

1 year ago·Canada

Read Full Article

Devdiscourse

Health News Roundup: Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot; Pfizer to invest more than $2.5 billion to expand European manufacturing and more

The drugmaker said on Friday it plans to spend more than 1.2 billion euros ($1.26 billion) to expand its Puurs, Belgium, manufacturing site, matching the investment at its Dublin, Ireland, plant announced on Thursday. Drop in COVID alertness could create deadly new variant - WHO Lapses in strategies to tackle COVID-19 this year continue to create the perfect conditions for a deadly new variant to emerge, as parts of China witness a rise in inf…

1 year ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.